Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for STP705 in adults with hypertrophic scars spanning Phase 1 and Phase 2, focusing on safety, tolerability, pharmacokinetics, immunogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar

Drugs mentioned

• STP705

Snippet

Sponsor: Sirnaomics | Conditions: Hypertrophic Scar | Phase 1, Phase 2 | Status: UNKNOWN